Target intelligence / Profile preview

Caseinolytic protease P1/P2 complex (ClpP1/P2)

Target
ClpP1/P2
Molecular classification
Enzyme, Serine protease, Proteasome-like complex
01

Overview

The Caseinolytic protease P1/P2 complex (ClpP1/P2) is an essential, ATP-dependent serine protease system found in Mycobacterium tuberculosis (Mtb). Unlike most bacteria that utilize a single ClpP homooligomer, Mtb requires a heterotetradecameric complex consisting of two distinct heptameric rings, ClpP1 and ClpP2, which must associate to become catalytically active (Akopian et al., 2012, Nature). This complex plays a vital role in bacterial proteostasis by degrading misfolded or damaged proteins, a process necessary for Mtb survival during both active growth and dormant phases of infection (Famulla et al., 2016, Molecular Microbiology). Because ClpP1/P2 is vital for Mtb viability and lacks a direct functional equivalent in the human cytosol, it has become a high-priority target for the development of next-generation antitubercular agents. Small molecules such as acyldepsipeptides (ADEPs) can bind to the complex and cause it to undergo uncontrolled proteolysis, effectively leading to bacterial self-digestion, while other molecules like lassomycin act as potent inhibitors by blocking the interaction with regulatory ATPases (Gavrish et al., 2014, Chemistry & Biology; Chou et al., 2014, JACS).

Other names
ClpP1P2Mycobacterium tuberculosis ClpP1/P2ClpP1-ClpP2 complexCaseinolytic protease PClpP1/2
02

Mechanism of action

Dysregulation of proteolytic activity via allosteric activation (leading to uncontrolled degradation) or direct inhibition of the proteolytic core.

03

Biological functions

Protein degradationProteostasisStress responseRegulation of protein quality control
04

Disease associations

InfectionTuberculosis
05

Safety considerations

Cross-reactivity with human mitochondrial ClpP (hClpP)Potential mitochondrial toxicityDevelopment of bacterial resistance through mutations in the ClpP active site or regulatory subunits
06

Interacting drugs

Acyldepsipeptide (ADEP)

5 more in the full profile.

07

Biomarkers

Bacterial load reduction (CFU)ClpP1/P2 expression levelsMisfolded protein accumulation

Beyond the preview

Go deeper on Caseinolytic protease P1/P2 complex (ClpP1/P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caseinolytic protease P1/P2 complex (ClpP1/P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call